PFE

#98
Pfizer, Inc. Common Stock
26.1 8 USD
+0.46%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
26.07
26.22
Jahresspanne
23.06
28.75
Tagesänderung
+0.46%
Monatliche Änderung
-0.80%
6 month change
+1.63%
Jahresänderung
+11.40%
Vorheriger Schlusskurs
26.0 6
Open
26.1 0
Tief
26.0 7
High
26.2 2
Volumen
7 045
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 149.21 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Arzneimittelhersteller – allgemein
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
21.2
Preis-Umsatz-Verhältnis
2.51
Dividende je Aktie
—
Dividendenrendite in %
9.29

Pfizer, Inc. Common Stock

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

Nachrichten